SCHEMBL19081591

SCHEMBL19081591

c1cc(-c2ccc3oc4c(ccc5c6ccc7ccccc7c6oc54)c3c2)cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 15/20 0.46
CYP1B1 Q16678 15/20 0.46
PLA2G2A P14555 2/20 0.40
PLA2G4A P47712 2/20 0.40
PLA2G10 O15496 1/20 0.40
CYP1A2 P05177 14/20 0.39
PRKDC P78527 3/20 0.39
ABCB1 P08183 2/20 0.39
ABCC1 P33527 2/20 0.39
ABCG2 Q9UNQ0 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PDE5A O76074 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16068029 0.97 CYP1A1 (0.48) CYP1A1CYP1B1PLA2G2APLA2G4APLA2G10
SCHEMBL16067596 0.97 CYP1A1 (0.48) CYP1A1CYP1B1PLA2G2APLA2G4APLA2G10
SCHEMBL22063356 0.95 CYP1A1 (0.46) CYP1A1CYP1B1PLA2G2APLA2G4APLA2G10
SCHEMBL22948590 0.94 CYP1A1 (0.45) CYP1A1CYP1B1PLA2G2APLA2G4APLA2G10
SCHEMBL16067968 0.94 CYP1A1 (0.51) CYP1A1CYP1B1CYP1A2PRKDCABCB1
SCHEMBL22063096 0.94 CYP1A1 (0.51) CYP1A1CYP1B1CYP1A2PRKDCABCB1
SCHEMBL10122396 0.92 PLA2G2A (0.41) CYP1A1CYP1B1PLA2G2APLA2G4APLA2G10
SCHEMBL10122423 0.92 PLA2G2A (0.41) CYP1A1CYP1B1PLA2G2APLA2G4APLA2G10
SCHEMBL10122438 0.92 PLA2G2A (0.41) CYP1A1CYP1B1PLA2G2APLA2G4APLA2G10
SCHEMBL17122670 0.92 CYP1A1 (0.50) CYP1A1CYP1B1CYP1A2PRKDCABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885PLA2G2A 4330/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885PLA2G2A 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.